Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

EP Biocomposites Ltd - 543595 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to intimate you that the Company has received an Order for Manufacturing, Supplying, Transporting and Installation of Garden Benches at various locations all over Goa from a major Government of Goa Undertaking. The order value is approximately INR 150.00 Lakh. You are hereby requested to disseminate the same. Thanking you, Yours faithfully, For EP Biocomposites Limited Akshada Neugui Company Secretary & Compliance Officer
05-06-2023
Bigul

EP Biocomposites Ltd - 543595 - Appointment Of Chief Executive Officer Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in its meeting held on Monday, May 29, 2023 has considered and approved the appointment of Mr. Anand Menon, as a whole-time Chief Executive Officer and Key Managerial Personnel of the Company with effect from May 29, 2023. The details required under Regulation 30 of the Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015, dated September 09, 2015 are enclosed as Annexure I. We request you to take the same on record. Thanking you, Yours faithfully, For EP Biocomposites Limited Akshada Neugui Company Secretary and Compliance Officer
30-05-2023
Bigul

EP Biocomposites Ltd - 543595 - Board Meeting Outcome for Outcome Of Board Meeting & Submission Of Audited Financial Statements For Year Ended March 31, 2023

 Dear Sir/Madam, Sub: Outcome of Board Meeting & Submission of Audited Financial Statements for Year ended March 31, 2023 In continuation of our intimation dated May 19, 2023 pursuant to regulation 33 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors (the "Board") of the Company was held today, on 29th May, 2023 and the Audited Financial Statements for year ended March 31, 2023, duly approved by the Board of Directors of the Company together with Statement of Assets and Liabilities and Independent Auditor's Report thereon are enclosed.
29-05-2023
Bigul

EP Biocomposites Ltd - 543595 - Order For Design, Drawings, Construction And Installation Of 2 Nos. Of 1 MLD Each Sewage Treatment Plants Based On Vertical Flow Constructed Wetlands Design From M/S. Hubballi-Dharwad Smart City Project For Their Green Mobility Corridor At Hubball.

 Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to intimate you that the Company has received an order for design, drawings, construction and installation of 2 Nos. of 1 MLD each Sewage Treatment Plants based on Vertical Flow Constructed Wetlands Design from M/s. Hubballi-Dharwad Smart City Project for their Green Mobility Corridor at Hubballi. The order value is approximately INR 265.00 Lakh. You are hereby requested to disseminate the same. Thanking you, Yours faithfully, For EP Biocomposites Limited Akshada Neugui Company Secretary & Compliance Officer
25-05-2023
Bigul

EP Biocomposites Ltd - 543595 - Board Meeting Intimation for Notice Of Board Meeting For Consideration And Adoption Of Financial Statements As At 31St March, 2023

 EP Biocomposites Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 ,inter alia, to consider and approve Dear Sir/Madam, Sub: Intimation of Board Meeting for the approval of draft Audited Financial Statements for year ended March 31, 2023 In relation to the above captioned matter, we wish to inform you that the 1st meeting of the Board of Directors of EP Biocomposites Limited for the financial year 2023-24 is scheduled to be held on Monday, May 29, 2023 at EP Kamat Group, First Floor, BR Commercial Centre, Opposite Parade Grounds, Campal, Panaji, Goa 403001 at 11.30 a.m. for the approval of draft Audited Financial Statements including the Balance Sheet, Profit and Loss Account and Cash Flow Statement along with annexures, schedules and note thereto for year ended March 31, 2023 . Further, in terms of Code of Conduct of the Company adopted under SEBI (Prohibition of Insider Trading) Regulations, 2015 the trading window for dealing in the securities of the Company is already closed and shall open 48 hours after conclusion of the Board Meeting. Kindly acknowledge and oblige. Thanking you.
19-05-2023
Bigul

EP Biocomposites Ltd - 543595 - Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 During The Period 01.04.2022 To 31.03.2023

 Dear Sir/Madam, In relation to the above mentioned caption, please find enclosed herewith Certificate from Bigshare Services Private Limited, in compliance with Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 during the period 01.04.2022 to 31.03.2023. Please take the above information on record. Thanking you, Yours faithfully, For EP Biocomposites Limited Akshada Neugui Company Secretary & Compliance Officer
22-04-2023
Bigul

EP Biocomposites Ltd - 543595 - Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2023

 Dear Sir/Madam, Pursuant to the provisions of Regulation 7(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 we hereby certify that all the activities in relation to share transfer facility are maintained by our Registrar to an issue and Share Transfer Agent, namely, Bigshare Services Private Limited, having permanent SEBI Registration No. INR000001385. Request you to kindly take note of the same.
22-04-2023
Bigul

EP Biocomposites Ltd - 543595 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Dear Sir/Madam, In relation to above mentioned caption, please find enclosed herewith Certificate from Bigshare Services Private Limited, in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on March 31, 2023. Please take the above information on record. Thanking you, Yours faithfully, For EP Biocomposites Limited Akshada Neugui Company Secretary & Compliance Officer
12-04-2023
Bigul

EP Biocomposites Ltd - 543595 - Closure of Trading Window

 Pursuant to the Company's Code of Conduct for Prevention of Insider Trading framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time, this is to inform you that the trading window for dealing in securities of the Company shall remain closed for all Designated Persons from April 01, 2023, till the completion of 48 hours after the declaration of Audited Financial Results of the Company for the year ended March 31, 2023. The date of meeting of the Board of Directors to approve the Audited Financial Results of the Company for the year ended March 31, 2023 will be informed in due course. Kindly take the above information on records and disseminate. Thanking you, Yours faithfully, For EP Biocomposites Limited Akshada Neugui Company Secretary & Compliance Officer
31-03-2023
Bigul

EP Biocomposites Ltd - 543595 - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Read With SEBI Circular CIR/CFD/CMD/4/2015 Dated September 09, 2015.

 Dear Sir/Madam, Pursuant to the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015 and the Policy On Materiality Of Events And Information of the Company, we write to intimate you that the Company has ventured into the production of Laminated Doors, which is an allied product to its current production of FRP Doors. The Company has successfully tested the production of this product and is ready for its commercial launch. After application of the Clause 5 of the Policy On Materiality Of Events And Information of the Company, it has been decided to disclose the attached information about the same.
09-03-2023
Next Page
Close

Let's Open Free Demat Account